138 related articles for article (PubMed ID: 16392745)
1. Public health vs. Philip Morris: is it a zero-sum game?
Daynard RA
J Public Health Policy; 2005 Dec; 26(4):469-73. PubMed ID: 16392745
[No Abstract] [Full Text] [Related]
2. Philip Morris' FDA gambit: good for public health?
Givel M
J Public Health Policy; 2005 Dec; 26(4):450-68. PubMed ID: 16392744
[TBL] [Abstract][Full Text] [Related]
3. Legislating "sound science": the role of the tobacco industry.
Baba A; Cook DM; McGarity TO; Bero LA
Am J Public Health; 2005; 95 Suppl 1():S20-7. PubMed ID: 16030333
[TBL] [Abstract][Full Text] [Related]
4. Tobacco product regulation--a public health approach.
Deyton L; Sharfstein J; Hamburg M
N Engl J Med; 2010 May; 362(19):1753-6. PubMed ID: 20410498
[No Abstract] [Full Text] [Related]
5. The need for FDA regulation of tobacco products.
Kennedy EM
Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428
[No Abstract] [Full Text] [Related]
6. Will congressional action go up in smoke? Overcoming obstacles in granting the FDA jurisdiction over tobacco products.
Kamensky DB
Georgetown Law J; 1998 Jul; 86(7):2677-701. PubMed ID: 10343052
[No Abstract] [Full Text] [Related]
7. The new image of tobacco smoking.
Fillon M
J Natl Cancer Inst; 2011 Sep; 103(18):1355-8. PubMed ID: 21881036
[No Abstract] [Full Text] [Related]
8. Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level?
Page JA
Food Drug Law J; 1998; 53 suppl():11-42. PubMed ID: 10342979
[No Abstract] [Full Text] [Related]
9. FDA legislation.
Givel M
Tob Control; 2007 Aug; 16(4):217-8. PubMed ID: 17652229
[TBL] [Abstract][Full Text] [Related]
10. A life-saving precedent: protecting public health policy against Big Tobacco.
Mulvey K
Tob Control; 2010 Apr; 19(2):95-7. PubMed ID: 20378584
[No Abstract] [Full Text] [Related]
11. Current tobacco control policy trends in the United States.
Stoner WI; Foley BX
Clin Occup Environ Med; 2006; 5(1):85-99, ix. PubMed ID: 16446256
[TBL] [Abstract][Full Text] [Related]
12. Clinton and tobacco: what now?
Simendinger A
Natl J (Wash); 1998 Nov; 30(47-48):2786-7. PubMed ID: 10339060
[No Abstract] [Full Text] [Related]
13. Tobacco policy: addressing public enemy number one.
Benjamin GC
Physician Exec; 2004; 30(4):62-3. PubMed ID: 15344650
[No Abstract] [Full Text] [Related]
14. Legal developments relevant to FDA authority.
Meron D
Food Drug Law J; 2007; 62(2):441-4. PubMed ID: 17632974
[No Abstract] [Full Text] [Related]
15. Supporting real advances in public health through FDA regulation.
Givel MS
J Public Health Policy; 2006; 27(1):119-20. PubMed ID: 16681191
[No Abstract] [Full Text] [Related]
16. Tobacco control: a state perspective.
Blumenthal R
Yale J Health Policy Law Ethics; 2002; 3(1):151-6. PubMed ID: 12825433
[No Abstract] [Full Text] [Related]
17. Repackaging cigarettes--will the courts thwart the FDA?
Bayer R; Gostin L; Marcus-Toll D
N Engl J Med; 2012 Nov; 367(22):2065-7. PubMed ID: 23151279
[No Abstract] [Full Text] [Related]
18. Menthol cigarettes: moving toward a broader definition of harm.
Gardiner P; Clark PI
Nicotine Tob Res; 2010 Dec; 12 Suppl 2():S85-93. PubMed ID: 21177372
[TBL] [Abstract][Full Text] [Related]
19. Courtesy and the challenges of implementing smoke-free policies in Japan.
Bialous SA; Mochizuki-Kobayashi Y; Stillman F
Nicotine Tob Res; 2006 Apr; 8(2):203-16. PubMed ID: 16766413
[TBL] [Abstract][Full Text] [Related]
20. Opposition in search of a rationale: the case for Food and Drug Administration regulation.
Myers ML
Tob Control; 2004 Dec; 13(4):441-3. PubMed ID: 15564634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
